Jeffrey P. Callen, M.D., FACP, FAAD, MACR

• Professor of Medicine
• Chief, Division of Dermatology
• Lafayette G. Owen, M.D. Endowed Chair of Dermatology

3810 Springhurst Blvd.
Louisville, KY 40241

502-322-1954 - Academic Office
502-583-1749 - Patient Appointments

Clinical Expertise
Skin Signs of Systemic Diseases; Lupus Erythematosus; Dermatomyositis; Pyoderma Gangrenosum; Psoriasis; Systemic Therapies for Management of Skin Disease

Featured Publications

• Brandling-Bennett HA, Arkin LM, Chiu YE, Hebert AA, Callen JP, Castelo-Soccio L, Co DO, Cordoro KM, Curran ML, Dalrymple AM, Flohr C, Gordon KB, Hanna D, Irvine AD, Kim S, Kirkorian AY, Lara-Corrales I, Lindstrom J, Paller AS, Reyes M, Begolka WS, Tom WL, Van Voorhees AS, Vleugels RA, Lee LW, Davies O, Siegfried EC. Executive summary: Consensus treatment guidelines for the use of methotrexate for inflammatory skin disease in pediatric patients. J Am Acad Dermatol. 2024 Jun;90(6):1271-1275. doi: 10.1016/j.jaad.2023.12.074. Epub 2024 Feb 9. PMID: 38342248; PMCID: PMC11096036.
• Kamal K, Xia E, Li SJ, Alavi A, Cogen AL, Firooz A, Marzano AV, Kaffenberger BH, Sibbald C, Fernandez AP, Callen JP, Dissemond J, Gontijo JRV, Shams K, Gerbens LA, French LE, Gould LJ, Bissonnette R, Shaigany S, Tolkachjov S, Yamamoto T, Wei-Ting Huang W, Ortega-Loayza AG, Mostaghimi A. Eligibility Criteria for Active Ulcerative Pyoderma Gangrenosum in Clinical Trials: A Delphi Consensus on Behalf of the UPGRADE (Understanding Pyoderma Gangrenosum: Review and Assessment of Disease Effects) Group. J Invest Dermatol. 2024 Jun;144(6):1295-1300.e6. doi: 10.1016/j.jid.2023.12.006. Epub 2023 Dec 16. PMID: 38110114.
• Akbarialiabad H, Jamshidi P, Callen JP, Murrell DF. Dermatologic manifestations of hereditary hemochromatosis: A systematic review. J Eur Acad Dermatol Venereol. 2024 May 16. doi: 10.1111/jdv.20098. Epub ahead of print. PMID: 38752605.
• Oldroyd AGS, Callen JP, Chinoy H, Chung L, Fiorentino D, Gordon P, Machado PM, McHugh N, Selva-O'Callaghan A, Schmidt J, Tansley SL, Vleugels RA, Werth VP; International Myositis Assessment and Clinical Studies Group Cancer Screening Expert Group; Aggarwal R. Author Correction: International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative. Nat Rev Rheumatol. 2024 May;20(5):315. doi: 10.1038/s41584-024-01111-x. Erratum for: Nat Rev Rheumatol. 2023 Dec;19(12):805-817. doi: 10.1038/s41584-023-01045-w. PMID: 38548933.
• Zaino ML, Schadt CR, Callen JP, Owen LG. Pyoderma Gangrenosum: Diagnostic Criteria, Subtypes, Systemic Associations, and Workup. Dermatol Clin. 2024 Apr;42(2):157-170. doi: 10.1016/j.det.2023.08.003. Epub 2023 Sep 7. Erratum in: Dermatol Clin. 2024 Jul;42(3):xiii. doi: 10.1016/j.det.2024.04.002. PMID: 38423678.
• Oldroyd AGS, Callen JP, Chinoy H, Chung L, Fiorentino D, Gordon P, Machado PM, McHugh N, Selva-O'Callaghan A, Schmidt J, Tansley SL, Vleugels RA, Werth VP; International Myositis Assessment and Clinical Studies Group Cancer Screening Expert Group; Aggarwal R. International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative. Nat Rev Rheumatol. 2023 Dec;19(12):805-817. doi: 10.1038/s41584-023-01045-w. Epub 2023 Nov 9. Erratum in: Nat Rev Rheumatol. 2024 May;20(5):315. doi: 10.1038/s41584-024-01111-x. PMID: 37945774; PMCID: PMC10834225.
• Callen JP. Dermatomyositis. JAMA Dermatol. 2023 Sep 1;159(9):1016. doi: 10.1001/jamadermatol.2023.1013. PMID: 37405743.
• Siegfried EC, Arkin LM, Chiu YE, Hebert AA, Callen JP, Castelo-Soccio L, Co DO, Cordoro KM, Curran ML, Dalrymple AM, Flohr C, Gordon KB, Hanna D, Irvine AD, Kim S, Kirkorian AY, Lara-Corrales I, Lindstrom J, Paller AS, Reyes M, Begolka WS, Tom WL, Van Voorhees AS, Vleugels RA, Lee LW, Davies OMT, Brandling-Bennett HA. Methotrexate for inflammatory skin disease in pediatric patients: Consensus treatment guidelines. Pediatr Dermatol. 2023 Sep-Oct;40(5):789-808. doi: 10.1111/pde.15327. Epub 2023 Jun 14. PMID: 37316462.
• Durbin A, Callen JP, Schadt CR. Proton pump inhibitor-induced subacute cutaneous lupus erythematosus. Dermatol Ther. 2022 Dec;35(12):e15959. doi: 10.1111/dth.15959. Epub 2022 Nov 6. PMID: 36284259.
• Perna DL, Callen JP, Schadt CR. Association of Treatment With Secukinumab With Exacerbation of Dermatomyositis in a Patient With Psoriasis. JAMA Dermatol. 2022 Apr 1;158(4):454-456. doi: 10.1001/jamadermatol.2021.6011. PMID: 35171205.